ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| SIRNA THERAPEUTICS INC Delisted | — | United States of America | — | 411 |
| Hamlet BioPharma AB | HAMLET | Sweden | — | 409 |
| Ym Biosciences Inc Delisted | YMI | United States of America | — | 409 |
| Argos Therapeutics Inc Delisted | ARGSQ | United States of America | — | 408 |
| Philogen | PHIL | Italy | — | 408 |
| Cellivery Therapeutics Inc Delisted | 268600 | South Korea | — | 405 |
| GLG Pharma Spółka Akcyjna Delisted | GLGPHARMA | Poland | — | 403 |
| Advanced Life Sciences Holdings, Inc. Delisted | — | United States of America | — | 401 |
| MiddleBrook Pharmaceuticals Inc Delisted | MBRKQ | United States of America | — | 401 |
| TiumBio Co., Ltd. | 321550 | South Korea | — | 399 |
| Decode Genetics Inc Delisted | DCGN | United States of America | — | 398 |
| Odonate Therapeutics, Inc. Delisted | — | United States of America | — | 398 |
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Delisted | — | United States of America | — | 398 |
| SHOUYAO HOLDINGS CO.,LTD | 688197 | China | — | 396 |
| JAVELIN PHARMACEUTICALS, INC Delisted | — | United States of America | — | 395 |
| Surface Oncology Inc Delisted | SURF | United States of America | — | 395 |
| Trillium Therapeutics Inc. Delisted | TRIL | Canada | — | 395 |
| GB SCIENCES INC Delisted | — | United States of America | — | 394 |
| Satellos Bioscience Inc. | MSCL | Canada | — | 394 |
| Pharnext Delisted | ALPHA | France | — | 392 |
| CohBar, Inc. Delisted | — | United States of America | — | 391 |
| EGF Theramed Health Corp. | TMED | Canada | — | 391 |
| Appili Therapeutics Inc. | APLI | Canada | — | 388 |
| Tobira Therapeutics, Inc. Delisted | — | United States of America | — | 387 |
| INTROGEN THERAPEUTICS INC Delisted | — | United States of America | — | 386 |
| Rebus Holdings, Inc. Delisted | — | United States of America | — | 386 |
| Ignyta, Inc. Delisted | — | United States of America | — | 385 |
| Trius Therapeutics Inc Delisted | — | United States of America | — | 383 |
| Entheon Biomedical Corp. | ENBI | Canada | — | 380 |
| Inozyme Pharma Inc Delisted | INZY | United States of America | — | 379 |
| Mural Oncology PLC Delisted | MURA | Ireland | — | 376 |
| Sophiris Bio Inc Delisted | SHS | Canada | — | 376 |
| Amarantus Bioscience Holdings, Inc. Delisted | — | United States of America | — | 372 |
| BIONOVO INC Delisted | — | United States of America | — | 370 |
| Forticell BioScience, Inc. Delisted | — | United States of America | — | 369 |
| Evelo Biosciences, Inc. Delisted | — | United States of America | — | 368 |
| RenovaCare, Inc. Delisted | — | United States of America | — | 367 |
| CHITOGENX INC | CHGX | Canada | — | 366 |
| Sirona Biochem Corp. | SRBCF | Canada | — | 366 |
| Voronoi, Inc. | 310210 | South Korea | — | 366 |
| ImmunoCellular Therapeutics Ltd. Warrants Delisted | IMUC-WS | United States of America | — | 365 |
| PhaseBio Pharmaceuticals Inc Delisted | PHAS | United States of America | — | 365 |
| Macrochem Corp Delisted | MACM | United States of America | — | 364 |
| PharmaLundensis AB | PHAL | Sweden | — | 362 |
| MedPacto, Inc. | 235980 | South Korea | — | 360 |
| Ensol Biosciences Inc. | 140610 | South Korea | — | 359 |
| Quest PharmaTech Inc. | QPT | Canada | — | 359 |
| GENITOPE CORP Delisted | — | United States of America | — | 358 |
| Asterias Biotherapeutics Inc Delisted | AST | United States of America | — | 357 |
| Delta-Fly Pharma, Inc. | 4598 | Japan | — | 357 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.